Steven P. Coen - 31 May 2024 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Chief Accounting Officer
Signature
/s/ Karen Tepichin, Attorney-in-Fact
Issuer symbol
DNA
Transactions as of
31 May 2024
Net transactions value
-$7,379
Form type
4
Filing time
05 Jun 2024, 17:06:57 UTC
Previous filing
06 May 2024
Next filing
05 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNA Class A Common Stock Options Exercise +23,496 +14% 186,023 31 May 2024 Direct F1
transaction DNA Class A Common Stock Options Exercise +6,249 +3.4% 192,272 31 May 2024 Direct F1
transaction DNA Class A Common Stock Sale $7,379 -13,440 -7% $0.5490 178,832 03 Jun 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Restricted Stock Units Options Exercise -23,496 -2.8% 822,369 31 May 2024 Class A Common Stock 23,496 Direct F1, F3
transaction DNA Restricted Stock Units Options Exercise -6,249 -2.2% 281,251 31 May 2024 Class A Common Stock 6,249 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2 Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
F3 The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.
F4 The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Remarks:

Chief Accounting Officer